Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Hematopoietic Stem Cell Transplant for Patients With Systemic Sclerosis and Cardiac Dysfunction
NCT03593902Phase 3Terminated
- Sponsor
- Northwestern University
- Start
- May 2018
- Primary completion
- Oct 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Autologous Mesenchymal Stem Cells in systemic sclerosis (SSc), sponsored by Northwestern University. Started May 2018; status: terminated.
02
Drugs
Autologous Mesenchymal Stem Cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT03593902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593902.